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To the Editor: With interest, we read the article reported by Liu 
et al.[1] about the frequency of central and peripheral auditory 
system affection in 73 patients with a mitochondrial disorder (MID) 
due to mitochondrial DNA (mtDNA) point mutations or a single 
mtDNA deletion. We had the following comments and concerns.
How can the authors be sure that impaired hearing (IH) was due to 
mtDNA‑mutations and not due to one of the frequent other genetic 
defects associated with IH?[2] Among those with a positive family 
history for IH, did the transmission follow a maternal trait in each 
case? How were genetic causes of IH other than the mtDNA‑defect 
excluded?
It would be interesting to know how quickly IH progressed over 
time? Were patients repeatedly investigated and did IH progress 
with the same degree in all patients? Did those with initially normal 
findings develop abnormalities over time? How many patients 
profited from hearing devices and or cochlear implants?
Involvement of the peripheral nerves or the cranial nerves is a 
frequent finding in MIDs but often neglected by physicians.[3] In 
how many of the patients was IH attributable to neuropathy of the 
8th cranial nerve and in how many of them was there affection of 
cranial nerves other than the acoustic nerve or of peripheral nerves? 
In how many patients was IH unilateral at onset and over which 
time did it progress to a bilateral problem?
The statement in the discussion that temporal asynchrony in central 
pathways or the auditory cortex should be diagnosed as auditory 
neuropathy spectrum disorder is contradictory. Why do the authors 
attribute a central nervous system problem to a peripheral nervous 
system disease?
Among those with IH due to affection of the central auditory 
pathways, was cerebral imaging indicative of an affection of the 
central auditory pathways as well?
There are indications that all MIDs sooner or later become 
multisystem diseases but that many patients do not survive 
that long. It is quite likely that also the auditory system will 
be sooner or later affected even in mono‑organ MIDs, like 
mitochondrial myopathy, hepatopathy, hypothyroidism, 
nephropathy, chronic progressive external ophthalmoplegia, 
or dilative cardiomyopathy. In addition, it should be stated 
that nonsyndromic MIDs with IH are much more frequent than 
syndromic MIDs with IH.
Since subgroups were not evenly distributed, it would be interesting 
to know if the results differed with regard to gender or with regard 
to young and old age.
There are several reasons why IH is frequently missed by the 
treating physicians. First, doctors do not know about the frequent 
association between MID and IH; second, doctors do not ask for 
IH when taking the history; third, doctors recognize IH but do not 
attribute enough attention to it; and fourth, patients do not mention 
IH because they do not want to admit that they are handicapped.
Overall, this interesting study could profit from more extensive 
evaluation of its data and from a long‑term follow‑up to eventually 
show that the frequency of IH increases with age, and that the 
auditory system may be affected even in MID‑patients with an 
initially mono‑organ problem.
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